{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Motesanib",
  "nciThesaurus": {
    "casRegistry": "453562-69-1",
    "chebiId": "CHEBI:51098",
    "chemicalFormula": "C22H23N5O",
    "definition": "An orally bioavailable receptor tyrosine kinase inhibitor with potential antineoplastic activity. AMG 706 selectively targets and inhibits vascular endothelial growth factor (VEGFR), platelet-derived growth factor (PDGFR), Kit, and Ret receptors, thereby inhibiting angiogenesis and cellular proliferation.",
    "fdaUniiCode": "U1JK633AYI",
    "identifier": "C71896",
    "preferredName": "Motesanib",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C1967"
    ],
    "synonyms": [
      "MOTESANIB",
      "Motesanib"
    ]
  }
}